Salicylic acid

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults is 500 mg administered orally every 12 hours. For pediatric patients aged 6 to 12 years, the dosage is 250 mg taken orally every 12 hours.

It is important to note that the maximum daily dosage should not exceed 2000 mg for adults and 1000 mg for pediatric patients. Administration should be performed orally, with a frequency of every 12 hours.

Contraindications

Use of this product is contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions.

Additionally, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is necessary.

Healthcare professionals should advise patients to avoid contact with eyes; if exposure occurs, the affected eye should be flushed with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory irritation.

Warnings and Precautions

For external use only, this product must be applied solely to the affected area. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

General precautions should be observed to ensure safe usage. Users must avoid contact with the eyes; in the event of exposure, it is essential to flush the eye with water for at least 15 minutes. Inhalation of vapors should also be avoided to minimize respiratory irritation. The bottle should be capped tightly after each use to maintain product integrity. Additionally, the product should be stored out of direct sunlight and at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Emergency medical help should be obtained without delay if the product is swallowed. Prompt action is crucial in such situations to ensure safety and appropriate care.

Side Effects

Patients should be aware that the product is for external use only and must be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event that discomfort persists after application, patients are advised to stop use and consult a healthcare professional. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Additionally, the product should be kept out of reach of children. In cases where the product is swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Liquid. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of WART REMOVER LIQUID during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals should exercise caution when considering the use of this product in pregnant patients due to the lack of data on potential risks or fetal outcomes. Women of childbearing potential should be advised to discuss their options with their healthcare provider to ensure appropriate management during pregnancy.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for WART REMOVER LIQUID. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not established. Lactating mothers should consult their healthcare provider for personalized advice regarding the use of this product while breastfeeding.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage typically involves supportive care and symptomatic treatment. It is recommended that healthcare providers assess the patient's condition thoroughly and initiate appropriate interventions based on the clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Patients should be informed to avoid contact with the eyes; in the event of contact, they should flush the eye with water for 15 minutes. It is also important to instruct patients to avoid inhaling vapors from the product.

Patients should be reminded to securely cap the bottle after each use and to store the product in a cool, dry place, away from direct sunlight and heat, ideally at room temperature.

Healthcare providers should counsel patients to discontinue use and seek medical advice if discomfort persists, or if they have diabetes or poor blood circulation. In the case of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain its integrity. It should be stored at room temperature, ensuring it is kept away from heat sources. Additionally, it is important to protect the product from direct sunlight to preserve its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Wart Remover Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)